Strados Labs, a medical technology company harnessing the power of smart sensors, machine learning and proprietary algorithms to provide early detection and predictions of...
REGENXBIO Inc. announced the clearance of its Investigational New Drug (IND) application by the United States Food and Drug Administration (FDA) to evaluate RGX-202,...
Valo Therapeutics Oy, the developer of novel, adaptable immunotherapy platforms for cancer and infectious diseases, announced the acquisition of intellectual property rights from the...
Dutch biotechnology company, Molecular Biology Systems, B.V. (MBS) has announced that both in silico and bench testing confirmed that the NextGenPCR PCR reagents detected...
